PP14 Recombinant Antibody

$K562 (H) cells were treated with or without PMA (2 ng\/ml) for 2 days, 25 \u03bcg total protein per lane of cell lysates (see on figure) probed with PP14 monoclonal antibody, unconjugated (bsm-62050R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min.$

K562 (H) cells were treated with or without PMA (2 ng\/ml) for 2 days, 25 \u03bcg total protein per lane of cell lysates (see on figure) probed with PP14 monoclonal antibody, unconjugated (bsm-62050R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min.

Applications

Reactivity

Human

Overview
Catalog #	bsm-62050r
Product Name	PP14 Recombinant Antibody
Applications	WB
Reactivity	Human
Specifications
Conjugation	Unconjugated
Host	Rabbit
Source	KLH conjugated synthetic peptide derived from human Glycodelin
Clonality	Recombinant
Isotype	IgG
Concentration	Lot dependent
Purification	Purified by Protein A.
Storage Buffer	0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Storage Condition	Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
Target
Gene ID	5047
Swiss Prot	P09466
Subcellular location	Secreted
Synonyms	GdA; GdF; GdS; Glycodelin A; Glycodelin; Glycodelin F; Glycodelin S; PAEG; PAEP; PEG; PEP; Placental protein 14; PP14.
Background	Glycoprotein that regulates critical steps during fertilization and also has immunomonomodulatory effects. Four glycoforms, namely glycodelin-S, -A, -F and -C have been identified in reproductive tissues that differ in glycosylation and biological activity. Glycodelin-A has contraceptive and immunosuppressive activities.
Application Dilution
WB	1:500-2000